Contact

Our portfolio

TrianecT

TrianecT develops StrokePointer, a portable EEG device that detects stroke severity in ambulances. The technology combines brain activity measurement through a proprietary headset with AI to diagnose Large Vessel Occlusion (LVO) strokes. Detection of an LVO stroke in the ambulance will allow patients to be immediately transported to a stroke center for timely treatment, to drastically improve the patient outcomes.

  • Institute: Amsterdam UMC
Industry: Diagnostics, Medical Technology, Stroke
  • Founding year: 2022
Visit website

Want to get in contact about TrianecT?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Deep Sleep Technologies
Enhancing deep sleep through real-time, non-invasive brainwave stimulation using adaptive, science-backed algorithms.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Pepper Therapeutics
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Skyline Dx
Advancing molecular diagnostics for precision oncology and infectious diseases.
Deep Sleep Technologies
Enhancing deep sleep through real-time, non-invasive brainwave stimulation using adaptive, science-backed algorithms.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Pepper Therapeutics
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Skyline Dx
Advancing molecular diagnostics for precision oncology and infectious diseases.
Explore full AAV portfolio
Contact